Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2012-03-01

FDA Approved: VIOKACE — Original Application (Aimmune Therapeutics, Inc.)

View source ↗

Summary

FDA approved Viokace (pancrelipase) via an original application from Aimmune Therapeutics, establishing a pancrelipase therapy for exocrine pancreatic insuffici…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • VIOKACE (PANCRELIPASE)

Snippet

ORIG AP for VIOKACE (PANCRELIPASE)